Table 1.

Prevalence of anti-HCV and HBsAg in the screened population stratified by gender

	Positive	Negative	Total	Prevalence (%)
Anti-HCV Abs
Female	3413	31,664	35,077	9.73
Male	6288	25,677	31,965	19.67
Total	9701	57,341	67,042	14.47
ORa for Male = 2.27; 95% CI 2.2–2.4
HBsAg
Female	965	34,097	35,062	2.75
Male	1982	29,963	31,945	6.20
Total	2947	64,060	67,007	4.40
OR for Male = 2.34; 95% CI 2.2–2.5
Anti-HCV & HBsAg
Female	24	35,038	35,062	0.07
Male	83	31,862	31,945	0.26
Total	107	66,900	67,007	0.16
OR for Male = 3.8; 95% CI 2.4–5.99

^aOR Odds ratio and CI Confidence Interval